Jean-François Dehecq

Dehecq was an executive at Elf Aquitaine who co-founded Sanofi in 1973 with a vision to convert oil profits into a recession-resistant healthcare business. As Managing Director and later CEO, he established the 'buy and build' acquisition strategy that defined Sanofi's early growth, integrating over ten small French laboratories within two years and acquiring Clin-Midy in 1980 to expand R&D capabilities. His decision to pursue the 2004 Aventis merger—initially as a defensive move against Novartis—transformed Sanofi into a global pharmaceutical leader.

Jean-François Dehecq (born 1940) is a French business executive who served as CEO of Sanofi from its founding in 1973 through the 2004 merger with Aventis. Trained as a pharmacist, Dehecq joined Elf Aquitaine before establishing Sanofi as a healthcare diversification vehicle. He led the company's expansion through serial acquisitions including Labaz, Clin-Midy, and Sterling Winthrop, building the foundation for Sanofi-Synthélabo's 1999 formation. His tenure culminated in the hostile takeover of Aventis, creating Sanofi-Aventis as Europe's largest pharmaceutical company. Dehecq retired in 2007, leaving a legacy of strategic M&A and European pharmaceutical consolidation.